Paediatric addendum to the guideline on clinical investigation of medicinal products for the treatment of pulmonary arterial hypertension

Current effective version

PDF iconAdopted guideline

Reference numberCHMP/EWP/213972/10
Published07/02/2012
Effective from05/06/2012
KeywordsPulmonary arterial hypertension (PAH), paediatric, persistent pulmonary hypertension of the newborn, congenital heart disease
DescriptionThis document is a paediatric addendum to the guideline on the clinical investigation of medicinal products for the treatment of pulmonary arterial hypertension. It includes guidance on paediatric clinical medicine development, with highlights on differences from adult pulmonary arterial hypertension and points out paediatric specific issues.


Document history

First version

Current version

PDF iconAdopted guideline

PDF iconDraft guideline

PDF iconConcept paper

In operation: 05/06/2012–present

Published: 04/06/2010

Published: 22/01/2009


Related content


How useful was this page?

Add your rating